Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Neurol ; 15(9): 998-1001, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18637954

ABSTRACT

BACKGROUND AND PURPOSE: In recent years, different approaches have been used to investigate changes of cerebrospinal fluid (CSF) proteome in patients affected by multiple sclerosis (MS) with the aim to identify protein markers with potential diagnostic or prognostic value. Because of the lack of standardization of current proteomic techniques, contrasting results were achieved until now in different laboratories. In this study, we compare CSF proteome of 10 relapsing-remitting MS (RR-MS) patients, 11 patients with clinically isolated syndrome (CIS), and 10 control subjects without neurological or systemic diseases. METHODS: The differential expression of CSF proteins amongst these cohorts of patients was investigated by using two-dimensional electrophoresis and mass spectrometry. RESULTS AND CONCLUSIONS: We found an overexpression of IgG free kappa light chain protein in both CIS and RR-MS patients, compared with control subjects and an increased expression of an apolipoprotein E isoform in RR-MS patients, compared with CIS and control groups. Our results confirm the presence of CSF proteome changes in MS patients. Future research should be aimed to investigate the role of these candidate CSF markers in larger cohorts of CIS and MS patients.


Subject(s)
Cerebrospinal Fluid Proteins/analysis , Electrophoresis, Gel, Two-Dimensional , Immunoglobulin kappa-Chains/cerebrospinal fluid , Nervous System Diseases/cerebrospinal fluid , Proteomics , Apolipoprotein A-I/cerebrospinal fluid , Apolipoproteins E/cerebrospinal fluid , Biomarkers/cerebrospinal fluid , Cohort Studies , Humans , Multiple Sclerosis, Relapsing-Remitting/cerebrospinal fluid , Prealbumin/cerebrospinal fluid
2.
Farmaco ; 45(5): 499-509, 1990 May.
Article in English | MEDLINE | ID: mdl-2222722

ABSTRACT

Some synthetic alkyl-lysophospholipid analogs have been described as a new class of immunopotentiating and antitumor agents. Among them, 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine has been reported to possess the highest antitumor activity. A new method for the synthesis of this compound and of the ethanolamine- and serine-containing analog is reported. 1-Alkyl-2-methyl-rac-glycerol, prepared from 1,2-isopropylidene-glycerol, is phosphorylated and the intermediate is condensed either with N-t-BOC-protected ethanolamine or with N-t-BOC-protected serine benzhydryl ester. The choline-derivative is obtained by methylation with CH3I of the ethanolamine derivative. The same synthetic sequence has been used also for synthesizing compounds unsaturated at the fatty alkyl chain in position 1 of the glycerol moiety. Preliminary observation are reported on the selective cytolytic action of the compounds on a tumor cell line.


Subject(s)
Antineoplastic Agents/chemical synthesis , Phospholipid Ethers/chemical synthesis , Animals , Cell Survival/drug effects , Chemical Phenomena , Chemistry , Lymphoma/pathology , Mice , Phospholipid Ethers/pharmacology , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...